Safety and clinical evaluation of dacomitinib: a new drug for metastatic non-small cell lung cancer

doi:10.3969/j.issn.1672-3384.2020.01.010

WU Yue-Tong, CHEN Qian, ZHAO Hua-ping, CAO Guo-Ying

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (1) : 40-44.

PDF(1173 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (1) : 40-44. DOI: 10.3969/j.issn.1672-3384.2020.01.010

Safety and clinical evaluation of dacomitinib: a new drug for metastatic non-small cell lung cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(1): 40-44 https://doi.org/10.3969/j.issn.1672-3384.2020.01.010

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1173 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-09-27	2020-01-31
Issue Date
2020-01-31

Please choose a citation manager

Content to export